04/10/2024 4:30 PM | Cadrenal Therapeutics (Issuer) Pham Quang X (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/09/2024 8:26 AM | Cadrenal Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/02/2024 11:15 PM | Cadrenal Therapeutics (Filer)
| Form EFFECT | |
03/20/2024 11:15 PM | Cadrenal Therapeutics (Filer)
| Form EFFECT | |
03/12/2024 7:37 AM | Cadrenal Therapeutics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/12/2024 7:04 AM | Cadrenal Therapeutics (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
03/11/2024 8:15 AM | Cadrenal Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
|
02/15/2024 7:00 AM | Cadrenal Therapeutics (Filer)
| Form 8-K/A | |
02/14/2024 2:34 PM | ARMISTICE CAPITAL, LLC (Filed by) Cadrenal Therapeutics (Subject)
| Form SC 13G | |
02/12/2024 8:41 PM | Cadrenal Therapeutics (Issuer) Pham Quang X (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/12/2024 8:42 PM | Cadrenal Therapeutics (Subject) Pham Quang X (Filed by)
| Form SC 13G | |
01/19/2024 6:38 PM | Cadrenal Therapeutics (Issuer) LOSORDO DOUGLAS W (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/19/2024 6:38 PM | Cadrenal Therapeutics (Issuer) WILSON GLYNN (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/19/2024 6:39 PM | Cadrenal Therapeutics (Issuer) Szot Matthew K (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/19/2024 6:40 PM | Cadrenal Therapeutics (Issuer) Pham Quang X (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/19/2024 6:41 PM | Cadrenal Therapeutics (Issuer) Lisicki Robert (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/19/2024 6:41 PM | Cadrenal Therapeutics (Issuer) MURPHY JOHN RAYMOND (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/19/2024 6:41 PM | Cadrenal Therapeutics (Issuer) Zelenkofske Steven (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/09/2023 8:15 AM | Cadrenal Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/09/2023 7:00 AM | Cadrenal Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
10/23/2023 4:04 PM | Cadrenal Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/06/2023 4:32 PM | Cadrenal Therapeutics (Issuer) MURPHY JOHN RAYMOND (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/06/2023 2:28 PM | Cadrenal Therapeutics (Issuer) Pham Quang X (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/05/2023 5:05 AM | Cadrenal Therapeutics (Issuer) Pham Quang X (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/28/2023 3:55 PM | Cadrenal Therapeutics (Filer)
| Form DEF 14A | |
08/28/2023 3:58 PM | Cadrenal Therapeutics (Filer)
| Form ARS | |
08/18/2023 5:06 AM | Cadrenal Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/16/2023 3:10 PM | Cadrenal Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/10/2023 8:16 AM | Cadrenal Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/10/2023 5:06 AM | Cadrenal Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/01/2023 5:06 AM | Cadrenal Therapeutics (Filer)
| Form 424B3 | |
07/30/2023 11:15 PM | Cadrenal Therapeutics (Filer)
| Form EFFECT | |
07/24/2023 4:25 PM | Cadrenal Therapeutics (Issuer) Lisicki Robert (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
07/24/2023 4:26 PM | Cadrenal Therapeutics (Issuer) Lisicki Robert (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/24/2023 8:20 AM | Cadrenal Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/24/2023 8:15 AM | Cadrenal Therapeutics (Filer)
| Form S-1 Registration statement under Securities Act of 1933 | |
07/14/2023 3:52 PM | Cadrenal Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/10/2023 8:03 AM | Cadrenal Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/10/2023 8:05 AM | Cadrenal Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |